emeerson's comments

It would take Googlmart 5+ years to play catch up if not longer.

Google's too disorganized and they don't have any supply chain tech built up. Amazon has years of supply chain infrastructure (both software, physical systems and organization) including supply/demand forecasting models and warehouse operational investment (Kiva systems, etc...).

The only differentiation that Google adds to Walmart is: - Top-talent engineering resources & brand which attracts talent to work on these problems - Layers of developer tooling and services that remove the "systems at scale" development curve of startups and smaller companies.

Now if Alibaba teamed up with Walmart... (read: acquired).

This is all true.

The flip side of this, however, is that "trial phase failure" does not conclude "ineffective biologic." There are many other variables to Clinical Trials, including flaws in trial design, time spent and difficulty in operations, and biased reporting:

https://well.blogs.nytimes.com/2013/01/14/clinical-trials-fl...

http://www.outsourcing-pharma.com/Preclinical-Research/Parki...

https://www.iths.org/blog/news/avoid-common-biostatistical-f...

No-tipping trends are starting to reverse now, however: http://www.theatlantic.com/business/archive/2016/05/why-rest...

Upscale and some midscale restaurants in NYC have seen a drop in demand since no-tipping policies have been applied. Its not clear if this is purely a product of pricing psychology, or if service quality at the upscale end starts to suffer with service staff having less incentive to provide top-notch service.

Other than intuitive observation of the creative class economy, this article offers neither a definition of "dominant, enduring social structures" nor evidence outside of GDP as a metric. So far it's like "duh GDP in this day and age is a product of high-density geographic regions." Am I missing something here?

Both the 5c/per ad and user-willingness-to-pay estimates are way optimistic. Ads you see probably has a CPM (cost per milleu, or thousand) of at $5 on the upper end and I'm guessing average around $1 CPM, which would be .5c and .1c respectively.

Facebook's per-user revenue in the US as of Q4 2015 was around $11/yr (source: http://www.businessinsider.com/facebook-average-revenue-per-...) although its grown by 50% yoy.

Chances are if FB / Twitter / Instagram had high confidence that could monetize their product with a subscription model averaging even $10/user a year I think they wouldn't hesitate to implement such a model.

This looks like a viable research route? New pathway for eliminating bacteria thats viral instead of antibiotic (fungal?) based:

http://www.sciencedaily.com/releases/2012/07/120724104640.ht...

Can anyone speak to the validity or promise of such research?

The author admits a valid case for eschewing miranda rights within the first paragraph. You can't make an argument for a constitutional right and say 'oh wait but there is an exception. and by the way this one might meet it.'